Lam Research Corporation $LRCX Stock Holdings Reduced by Associated Banc Corp

Associated Banc Corp reduced its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 13.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 836,296 shares of the semiconductor company’s stock after selling 132,006 shares during the quarter. Lam Research accounts for approximately 2.9% of Associated Banc Corp’s portfolio, making the stock its 7th largest holding. Associated Banc Corp owned 0.07% of Lam Research worth $111,980,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. IMG Wealth Management Inc. acquired a new stake in shares of Lam Research in the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute purchased a new stake in Lam Research during the second quarter worth $27,000. Strategic Wealth Investment Group LLC purchased a new position in shares of Lam Research in the second quarter valued at $29,000. Delos Wealth Advisors LLC acquired a new position in shares of Lam Research during the 2nd quarter worth $30,000. Finally, REAP Financial Group LLC purchased a new stake in shares of Lam Research in the 2nd quarter worth about $31,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have weighed in on LRCX. Berenberg Bank raised their target price on shares of Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Evercore ISI raised their price objective on shares of Lam Research from $115.00 to $170.00 and gave the stock an “outperform” rating in a research note on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft lifted their price objective on Lam Research from $160.00 to $195.00 and gave the stock a “buy” rating in a research report on Friday, December 19th. Needham & Company LLC increased their target price on Lam Research from $150.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Hsbc Global Res raised Lam Research to a “hold” rating in a research report on Tuesday, September 30th. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $164.37.

Insider Activity at Lam Research

In related news, insider Ava Harter sold 9,010 shares of the stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the completion of the sale, the insider owned 56,786 shares of the company’s stock, valued at approximately $8,942,091.42. This represents a 13.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the stock in a transaction on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president directly owned 251,047 shares of the company’s stock, valued at $34,870,428.30. The trade was a 17.21% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 102,608 shares of company stock valued at $14,916,496 over the last three months. Insiders own 0.31% of the company’s stock.

Lam Research Stock Up 8.7%

LRCX stock opened at $218.36 on Friday. The company has a 50 day moving average price of $165.99 and a two-hundred day moving average price of $133.06. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The stock has a market capitalization of $274.27 billion, a P/E ratio of 48.10, a PEG ratio of 2.52 and a beta of 1.77. Lam Research Corporation has a one year low of $56.32 and a one year high of $219.59.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business’s revenue was up 27.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, sell-side analysts expect that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd were issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Wednesday, December 3rd. Lam Research’s dividend payout ratio is presently 22.91%.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.